BACTEK-R Withdrawn Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Prevention
Indications | Status | Purpose | Phase |
---|---|---|---|
Withdrawn | Prevention | 3 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT04452643 | Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel |